Getting Up to Speed on the Evolving Landscape of Multiple Sclerosis: Annette Okai, MD


The medical director of the North Texas Institute of Neurology and Headache offered an overview of the State of the Science Summit that was held on July 21, 2022, with a variety of expert clinicians in MS care. [WATCH TIME: 3 minutes]

WATCH TIME: 3 minutes

NeurologyLive® State of the Science events are short meetings designed to educate neurologists and APPs on the clinical benefits associated with the new science driving new thinking. Our renowned faculty focuses on the most relevant topics to ultimately improve patient care.

In this recent event, held on July 21, 2022, a panel of experts in the care of multiple sclerosis (MS) convened to discuss the drastic evolution of MS therapeutic approaches in the past 30 years, as well as to detail some of the latest entrants into the treatment toolbox. This conversation included overviews of the recent oral medications and B cell depleters, and a look into what investigational treatments are on the horizon for the field.


  • The Evolving Landscape of Multiple Sclerosis - Mechanisms of Action and Targets of Treatment — Fernando Cuascut, MD, MPH
  • FDA Approved Oral Medications for MS — Lauren Tardo, MD
  • FDA Approved B Cell Depleting Medications for MS — Rebecca Romero, MD
  • Emerging Treatments for MS — Annette Okai, MD

Click the button below to watch the recent State of the Science Summit with Okai et al.

Insitutional Perspectives in Neurology, Chaired by Annette Okai MD
Related Videos
Video 2 - 4 KOLs are feature in, "Changes in Presentation of Spasticity Over Time"
Video 1 - 4 KOLs are feature in, "Definition and Pathophysiology of Spasticity"
Dolores D. Santamaria, MD
 Bruce Cree, MD, PhD, MAS, FAAN
Video 3 - 5 KOLs are featured in "Transitions of Care: Moving Spinal Muscular Atrophy Patients from Pediatric/Adolescent Care to Adult Clinics"
Video 3 - 5 KOLs are featured in "Presentation of Adult Spinal Muscular Atrophy in Clinics"
Fawad Khan, MD, FACNS
© 2024 MJH Life Sciences

All rights reserved.